Sale of shares in Humana AB (publ)

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, SWITZERLAND, SOUTH AFRICA, SINGAPORE, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

­Argan Capital through Air Syndication Sca (“Argan Capital”), has sold 6,000,000 shares in Humana AB (publ) ("Humana") through an accelerated bookbuilding to Swedish and international investors at a price of SEK 74.00 per share (“the placing”).

Following the placing, Argan Capital owns 23,606,290 shares in Humana corresponding to 44.4% of the total number of shares and votes. Subject to customary exceptions or obtaining consent from ABGSC and Carnegie, Argan Capital has agreed to a lock-up period until publication of the next interim report, which is expected to be published on 23 February 2017, in relation to its remaining shares in Humana.

ABG Sundal Collier AB (“ABGSC”) and Carnegie Investment Bank AB (“Carnegie”) have acted as joint bookrunners in connection with the placing.
  

Argan Capital,
24 November 2016

 
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, SWITZERLAND, SOUTH AFRICA, SINGAPORE, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL